Modulation of Anti-Adhesion Molecule MUC-1 Is Associated with Arctiin-Induced Growth Inhibition in PC-3 Cells

Prostate

Volumn 59, Issue 3, 2004, Pages 260-267

  Huang, Dong Ming ^a   Guh, Jih Hwa ^a   Chueh, Shih Chieh ^a   Teng, Che Ming ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Adhesion; Arctiin; MUC 1; PC 3 cells

Indexed keywords

ALPHA2 INTEGRIN; ALPHA5 INTEGRIN; ARCTIIN; BETA1 INTEGRIN; MUCIN 1;

ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL ADHESION; CELL COUNT; CELL GROWTH; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; MALE; NITROBLUE TETRAZOLIUM TEST; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

CA-15-3 ANTIGEN; CELL ADHESION; DRUGS, CHINESE HERBAL; FLOW CYTOMETRY; FURANS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSIDES; HUMANS; KINETICS; MALE; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 1942475772     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.10364     Document Type: Article

References (27)

1. Zotter S, Hageman PC, Lossnitzer A, van den Tweel J, Hilkens J, Mooi WJ, Hilgers J. Monoclonal antibodies to epithelial sialomucins recognize epitopes at different cellular sites in adenolymphomas of the parotid gland. Int J Cancer Suppl 1988;3:38-44.
2. Gendler SJ. MUC1, the renaissance molecule. J Mammary Gland Biol Neoplasia 2001;6:339-353.
3. Hilkens J, Ligtenberg MJ, Vos HL, Litvinov SV. Cell membrane-associated mucins and their adhesion-modulating property. Trends Biochem Sci 1992;17:359-363.
4. Hilkens J, Vos HL, Wesseling J, Boer M, Storm J, van der Valk S, Calafat J, Patriarca C. Is episialin/MUC1 involved in breast cancer progression? Cancer Lett 1995;90:27-33.
5. Wesseling J, van der Valk SW, Vos HL, Sonnenberg A, Hilkens J. Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components. J Cell Biol 1995;129:255-265.
6. Makiguchi Y, Hinoda Y, Imai K. Effect of MUC1 mucin, an anti-adhesion molecule, on tumor cell growth. Jpn J Cancer Res 1996;87:505-511.
7. Regimbald LH, Pilarski LM, Longenecker BM, Reddish MA, Zimmermann G, Hugh JC. The breast mucin MUC1 as a novel adhesion ligand for endothelial intracellular adhesion molecule 1 in breast cancer. Cancer Res 1996;56:4244-4249.
8. Kirschenbaum A, Itzkowitz SH, Wang JP, Yao S, Eliashvili M, Levine AC. MUC1 expression in prostate carcinoma: Correlation with grade and stage. Mol Urol 1999;3:163-168.
9. Schut IC, Waterfall PM, Ross M, O'Sullivan C, Miller WR, Habib FK, Bayne CW. MUC1 expression, splice variant and short form transcription (MUC1/Z, MUC1/Y) in prostate cell lines and tissue. BJU Int 2003;91:278-283.
10. Griffiths K, Morton MS, Denis L. Certain aspects of molecular endocrinology that relate to the influence of dietary factors on the pathogenesis of prostate cancer. Eur Urol 1999;35:443-455.
11. Botta B, Delle Monache G, Misiti D, Vitali A, Zappia G. Aryltetralin lignans: Chemistry, pharmacology, and biotransformations. Curr Med Chem 2001;8:1363-1381.
12. Adlercreutz H, Mazur W. Phyto-oestrogens and Western diseases. Ann Med 1997;29:95-120.
13. Luyengi L, Suh N, Fong HH, Pezzuto JM, Kinghom AD. A lignan and four terpenoids from Brucea javanica that induce differentiation with cultured HL-60 promyelocytic leukemia cells. Phytochemistry 1996;43:409-412.
14. Apers S, Paper D, Burgermeister J, Baronikova S, Van Dyck S, Lemiere G, Vlietinck A, Pieters L. Antiangiogenic activity of synthetic dihydrobenzofuran lignans. J Nat Prod 2002;65:718-720.
15. Lee C, Kim H, Kho Y. Agastinol and agastenol, novel lignans from Agastache rugosa and their evaluation in an apoptosis inhibition assay. J Nat Prod 2002;65:414-416.
16. Gotoh T, Yamada K, Yin H, Ito A, Kataoka T, Dohi K. Chemoprevention of N-nitroso-N-methylurea-induced rat mammary carcinogenesis by soy foods or biochanin A. Jpn J Cancer Res 1998;89:137-142.
17. Hirose M, Yamaguchi T, Lin C, Kirnoto N, Futakuchi M, Kono T, Nishibe S, Shirai T. Effects of arctiin on PhIP-induced mammary, colon and pancreatic carcinogenesis in female Sprague-Dawley rats and MeIQx-induced hepatocarcinogenesis in male F344 rats. Cancer Lett 2000;155:79-88.
18. Moritani S, Nomura M, Takeda Y, Miyamoto K. Cytotoxic components of bardanae fructus (goboshi). Biol Pharm Bull 1996;19:1515-1517.
19. Takasaki M, Konoshima T, Komatsu K, Tokuda H, Nishino H. Anti-tumor-promoting activity of lignans from the aerial part of Saussurea medusa. Cancer Lett 2000;158:53-59.
20. Evangelou A, Letarte M, Marks A, Brown TJ. Androgen modulation of adhesion and antiadhesion molecules in PC-3 prostate cancer cells expressing androgen receptor. Endocrinology 2002;143:3897-3904.
21. Price MR, Pugh JA, Hudecz F, Griffiths W, Jacobs E, Symonds IM, Clarke AJ, Chan WC, Baldwin RW. C595-a monoclonal antibody against the protein core of human urinary epithelial mucin commonly expressed in breast carcinomas. Br J Cancer 1990;61:681-686.
22. Kato T, Hirose M, Takahashi S, Hasegawa R, Kohno T, Nishibe S, Kato K, Shirai T. Effects of the lignan, arctiin, on 17-β ethinyl estradiol promotion of preneoplastic liver cell foci development in rats. Anticancer Res 1998;18:1053-1058.
23. McGuckin MA, Walsh MD, Hohn BG, Ward BG, Wright RG. Prognostic significance of MUC1 epithelial mucin expression in breast cancer. Hum Pathol 1995;26:432-439.
24. Van de Wiel-van Kemenade E, Ligtenberg MJ, de Boer AJ, Buijs F, Vos HL, Melief CJ, Hilkens J, Figdor CG. Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction. J Immunol 1993;151:767-776.
25. Rowse GJ, Tempero RM, VanLith ML, Hollingsworth MA, Gendler SJ. Tolerance and immunity to MUC1 in a human MUC1 transgenic murine model. Cancer Res 1998;58:315-321.
26. Agrawal B, Krantz MJ, Reddish MA, Longenecker BM. Cancer-associated MUC1 mucin inhibits human T-cell pfoliferation, which is reversible by IL-2. Nat Med 1998;4:43-49.
27. Kontani K, Taguchi O, Narita T, Izawa M, Hiraiwa N, Zenita K, Takeuchi T, Murai H, Miura S, Kannagi R. Mudulation of MUC1 mucin as an escape mechanism of breast banker cells from autologous cytotoxic T-lymphocytes. Br J Cancer 2001;84:1258-1264.